Correlation Between Alterola Biotech and HLS Therapeutics

Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alterola Biotech and HLS Therapeutics, you can compare the effects of market volatilities on Alterola Biotech and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and HLS Therapeutics.

Diversification Opportunities for Alterola Biotech and HLS Therapeutics

-0.41

Correlation Coefficient

Alterola Biotech  HLS Therapeutics

Very good diversification

The 3 months correlation between Alterola and HLS is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and HLS Therapeutics go up and down completely randomly.

Pair Corralation between Alterola Biotech and HLS Therapeutics

Given the investment horizon of 90 days Alterola Biotech is expected to under-perform the HLS Therapeutics. In addition to that, Alterola Biotech is 2.58 times more volatile than HLS Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. HLS Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest  273.00  in HLS Therapeutics on December 3, 2024 and sell it today you would earn a total of  18.00  from holding HLS Therapeutics or generate 6.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	80.95%
Values	Daily Returns

Alterola Biotech  vs.  HLS Therapeutics

Alterola Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Alterola Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

HLS Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Alterola Biotech and HLS Therapeutics

The main advantage of trading using opposite Alterola Biotech and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.

The idea behind Alterola Biotech and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.